The Alzheimer's Drug Discovery Foundation and The Michael J. Fox Foundation Launch $5 Million Partnership to Target Key Co-Pathologies Driving Alzheimer's and Parkinson's

Summary

The Alzheimer's Drug Discovery Foundation and The Michael J. Fox Foundation announced a $5 million partnership to accelerate biomarker development for Alzheimer's and Parkinson's diseases. The collaboration aims to advance scalable, minimally invasive diagnostic tools to support precision medicine approaches for these conditions.